About UsInvestors
Video
Learn more about DermTech’s EGIR™ Technology »
Melanoma Facts
- By 2010, current estimates indicate 1:50 people will be diagnosed with melanoma during their lifetime.
- Melanoma is the most common cancer in women aged 25-29.
- If melanoma is treated before it spreads, it is 99% curable.
Headquartered in La Jolla, California, DermTech International develops molecular biology assays to identify, diagnose and/or analyze any number of disease states or conditions, the genetic footprints of which can be found on the stratum corneum by using DermTech's proprietary EGIR™ technology. If you wish to learn more, please contact us:
George Schwartz
Chief Executive Officer
DermTech International Inc.
Ph: (858) 450-4222
Cel: (619) 417-3285
gschwartz@dermtech.com